Aberrant Salience

Aberrant Salience

Aberrant salience is an account of how psychotic symptoms arise in which the primary fault is not in belief but in importance. Dopamine is held to mark what matters, so that attention goes where it is worth going, and when that marking runs without regard to what is actually significant, ordinary things start to feel charged with meaning. The account is Shitij Kapur's. It is one of the more productive frameworks in psychosis research and it is also a partial one, because the dopamine hypothesis it rests on does not explain the whole disorder and has named rivals.

What it is

The construct reframes what a delusion is. On the standard picture, a false belief comes first and the strangeness of experience follows from it. On Kapur's picture, the experience of significance comes first and the delusion is the explanation a person builds afterwards for something that has already happened to them.

The everyday version the construct rests on is the difference between a number plate you do not notice and the same number plate seeming addressed to you. Nothing about the plate has changed. What has changed is the weight the brain has put on it.

This vault's record of the idea comes from a popular retelling rather than from the primary paper. Our note dates the account to 2003, but that date comes from our own ingestion digest and has not been independently checked, so the primary citation should be confirmed before any of this reaches body copy.

In effect

The clinical corollary is what antipsychotic medication does to the experience. These drugs reduce activity in the same dopamine system, which is why they act on positive symptoms first, dampening the sense of charged significance before they dislodge the belief a person has built on top of it. That ordering is the framework's best argument for itself, because it is what a salience account predicts and a belief-first account does not.

The framework also explains why delusions so often take the particular shapes they take, concerning reference, significance and being singled out. If the fault is in the marking of importance, then content about importance is what the mind will reach for.

This page is written from Lieberman and Long's popular account, which runs the idea across five pages of The Molecule of More without naming Kapur anywhere. We record that as a citation failure in a trade book rather than as a problem with the construct.

What it does not say

It does not say the dopamine hypothesis of schizophrenia is settled. It is a partial account, and our audit of the popular source records that no rival is named anywhere in that book: no glutamate model and no neurodevelopmental account.

It does not say the framework covers the whole disorder. Dopamine blockade treats positive symptoms while leaving negative and cognitive symptoms largely untouched, which is the clearest limit on how much of psychosis a salience account can carry.

It does not license any claim about medication for a reader. The popular source puts receptor occupancy figures into a trade paperback, and those numbers should not travel out of the careful clinical context they sit in. This is clinical material about a diagnosed population and nothing here is a guide to treatment.

It does not support the rhetorical move the same chapter goes on to make, in which disorganised speech is printed facing verse and creative people are likened to people with mental illness. That is rhetoric doing work the evidence does not do.

Sources

  1. Kapur, S. The aberrant salience account of psychosis. Our note records the year as 2003 from the vault's own ingestion digest, which has not been independently checked. Confirm the primary citation before publication.
  2. Lieberman, D. Z., & Long, M. E. (2018). The Molecule of More. BenBella Books, pp. 112 to 116. Cited only as the route by which the idea was popularised. The account and the fast dissociation explanation of newer antipsychotics at p. 116 are both Kapur's and neither is credited. The book has no endnotes, no superscripts and no bibliography, only per-chapter further reading lists that map to nothing.
  3. Carried as a caution: the receptor occupancy dosing figures at p. 116 are not reproduced here.